https://evommune-com.agentsite.network/index.html 2026-07-26 daily 0.9 https://evommune-com.agentsite.network/content/wp-content/uploads/2025/09/2025_focis_evommune-pdf.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/wp-content/uploads/2023/12/evo756_poster_pr-pdf.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/team/kyle-carver-mba-cpa/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/wp-content/uploads/2026/05/evommune_2026_sid_evo301_poster-pdf.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/financial-information/sec-filings/content/0001193125-25-315972/evmn-ex31_1-htm.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/wp-content/uploads/2025/11/evommune_2025_isds_evo756_poster-pdf.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/wp-content/uploads/2024/03/18_evommune_maruho_press_release_032024_2-pdf.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/news-events/press-releases/detail/117/evommune-announces-closing-of-its-initial-public-offering-and-full-exercise-of-underwriters-option-to-purchase-additional-shares.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/financial-information/sec-filings/content/0002092017-26-000007/primarydocument-html.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/team/rob-hopfner-rph-phd-mba/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/financial-information/sec-filings/content/0001193125-26-211963/evmn-20260331-htm.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/company-info/presentations/rss/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/financial-information/sec-filings/content/0001193125-26-211963/evmn-ex32_1-htm.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/financial-information/sec-filings/content/0001193125-26-093932/evmn-ex4_3-htm.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/financial-information/sec-filings/content/0001193125-26-093932/evmn-ex97-htm.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/news-events/press-releases/detail/85/evommune-presents-full-phase-2-data-for-oral-mrgprx2-inhibitor-evo756-in-chronic-inducible-urticaria-during-late-breaker-at-eadv-2025-congress.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/publications-posters/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/financial-information/sec-filings/content/0001193125-26-093932/evmn-ex19_1-htm.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/financial-information/sec-filings/content/0000919574-26-004453/p15032823_ex99-1-htm.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/team/luis-pena/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/disclaimer/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/financial-information/sec-filings/content/0001216994-26-000003/primarydocument-html.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/news-events/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/news-events/press-releases/detail/122/evommune-to-host-kol-webinar-on-april-13-2026-highlighting-the-potential-of-mrgprx2-inhibition-in-migraine.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/news-events/press-releases/detail/124/evommune-announces-top-line-results-from-evo756-phase-2b-trial-in-moderate-to-severe-chronic-spontaneous-urticaria.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/clinical-trials/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/mrgprx2-antagonist/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/financial-information/sec-filings/content/0001193125-26-093932/evmn-ex31_1-htm.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/stock-data/historical-data/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/accessibility-statement/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/wp-content/uploads/2023/12/evommune_privacy-statement_for_website-pdf.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/rss-news-feed/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/company-info/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/team/lou-sehl-phd/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/team/felice-verduyn-van-weegen/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/team/daniel-j-burge-m-d/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/news-events/press-releases/rss/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/team/arthur-kirsch/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/company-info/contacts/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/company-info/faq/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/il-18bp-fusion-protein/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/financial-information/financial-results/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/team/eugene-a-bauer-md/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/news-events/ir-calendar/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/financial-information/sec-filings/content/0001193125-26-286924/evmn-2026-june_29_424b3-htm.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/news-events/press-releases/detail/118/evommune-reports-third-quarter-2025-financial-results-and-provides-business-update.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/team/lorena-riol-blanco-ph-d/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/news-events/press-releases/detail/121/evommune-reports-fourth-quarter-and-full-year-2025-financial-results-and-provides-business-highlights.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/financial-information/sec-filings/content/0001193125-26-286918/evmn-20260629-htm.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/wp-content/uploads/2025/09/042425_aai_2025_evommune-pdf.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/financial-information/sec-filings/rss/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/disease-focus/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/news-events/ir-calendar/detail/20260210-evommune-evo301-top-line-results-from-phase-2a-trial-in-moderate-to-severe-atopic-dermatitis.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/news-events/press-releases/detail/119/evommune-announces-positive-top-line-datafrom-phase-2a-proof-of-concept-trial-of-evo301-in-moderate-to-severe-atopic-dermatitis.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/team/janice-drew-mph/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/privacy-policy/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/wp-content/uploads/2026/06/evommune_ahs_presentation_role_of_mrgprx2_in_migraine-pdf.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/company-info/presentations/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/financial-information/sec-filings/content/0001193125-26-211963/evmn-ex31_2-htm.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/wp-content/uploads/2023/12/evommune_mrgpr_poster_wci_2023-pdf.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/wp-content/uploads/2025/11/evommune_2025_isds_evo301_poster-pdf.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/wp-content/uploads/2024/01/16_evommune_accutar_biotechnology_announce_ai-drug_discovery_collaboration_003_112823_2-pdf.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/financial-information/sec-filings/content/0001620548-26-000007/primarydocument-html.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/wp-content/uploads/2024/12/evommune_guf_2024_evo756-hv001_oral_presentation_22nov2024_2-pdf.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/financial-information/sec-filings/content/0001757072-26-000007/primarydocument-html.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/news-events/ir-calendar/detail/20260602-2026-annual-meeting-of-stockholders/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/team/derek-dirocco-ph-d/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/news-events/press-releases/detail/123/evommune-reports-first-quarter-2026-financial-results-and-provides-business-highlights.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/wp-content/uploads/2025/09/2025_sid_evommune-pdf.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/news-events/ir-calendar/detail/20260413-kol-webinar-highlighting-role-of-mrgprx2-in-migraine.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/news-events/press-releases/detail/119/evommune-announces-positive-top-line-data-from-phase-2a-proof-of-concept-trial-of-evo301-in-moderate-to-severe-atopic-dermatitis.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/financial-information/sec-filings/content/0001193125-25-315972/evmn-20250930-htm.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/financial-information/sec-filings/content/0001193125-26-093932/evmn-ex31_2-htm.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/about-us/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/accessibility-request-form/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/financial-information/sec-filings/content/0001193125-25-315972/evmn-ex32_1-htm.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/our-culture/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/team/david-e-cohen-md-mph/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/stock-data/analyst-coverage/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/team/jeegar-patel-phd/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/governance/governance-documents/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/team/benjamin-f-mcgraw-iii-pharmd-chair-of-board/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/news-events/press-releases/detail/116/evommune-announces-pricing-of-its-initial-public-offering.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/news-events/email-alerts/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/wp-content/uploads/2026/06/evommune_focis_2026_proteomic_profiling_poster-pdf.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/governance/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/team/j-mark-jackson-md/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/team/sam-chi-m-b-a/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/financial-information/sec-filings/content/0002091053-26-000005/primarydocument-html.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/financial-information/sec-filings/content/0001193125-26-211963/evmn-ex31_1-htm.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/financial-information/sec-filings/content/0001950047-26-006381/primary_doc-html.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/financial-information/sec-filings/content/0001193125-26-093932/evmn-ex32_1-htm.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/financial-information/sec-filings/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/approach/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/stock-data/quote-chart/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/team/gregory-s-moss-esq/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/news-events/press-releases/detail/120/evommune-announces-125-million-private-placement/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/financial-information/sec-filings/content/0001193125-26-093932/evmn-ex21_1-htm.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/wp-content/uploads/2024/12/evommune_ucare_poster-pdf.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/team/luis-pena-2/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/team/eugene-a-bauer-m-d/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/development-pipeline/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/news-events/press-releases/detail/115/evommune-announces-commencement-of-initial-public-offering.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/news-events/ir-calendar/past/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/financial-information/sec-filings/content/0001193125-26-286918/evmn-ex99_1-htm.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/site-root.html 2026-07-26 monthly 1.0 https://evommune-com.agentsite.network/content/job-openings/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/financial-information/sec-filings/content/0001290976-26-000004/primarydocument-html.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/news-events/press-releases/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/collaborating/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/governance/board-committees/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/wp-content/uploads/2024/05/evommune_aai_2024_poster_final-pdf.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/financial-information/index.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/financial-information/sec-filings/content/0001193125-26-093932/evmn-ex23_1-htm.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/ir/financial-information/sec-filings/content/0000919574-26-004453/primary_doc-html.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/wp-content/uploads/2025/09/2025_cell-neuro-immune-axis-symposia-poster-pdf.html 2026-07-26 monthly 0.8 https://evommune-com.agentsite.network/content/contact/index.html 2026-07-26 monthly 0.8